de Luca Montes, Ricardo Azêdo
Huq, Molla
Godfrey, Timothy
Oon, Shereen
Calderone, Alicia
Kandane-Rathnayake, Rangi
Louthrenoo, Worawit
Luo, Shue-Fen
Jan Wu, Yeong-Jian
Golder, Vera
Lateef, Aisha
Navarra, Sandra V.
Zamora, Leonid
Hamijoyo, Laniyati
Sockalingam, Sargunan
An, Yuan
Li, Zhanguo
Katsumata, Yasuhiro
Harigai, Masayoshi
Chan, Madelynn
Goldblatt, Fiona
O’Neill, Sean
Lau, Chak Sing
Cho, Jiacai
Hoi, Alberta
Karyekar, Chetan S.
Morand, Eric F.
Nikpour, Mandana http://orcid.org/0000-0002-6585-5611
Funding for this research was provided by:
National Health and Medical Research Council (GTN1176538)
GlaxoSmithKline foundation (ISS 209462)
Janssen Pharmaceuticals
AstraZeneca
Bristol-Myers Squibb
Merck Serono
Eli Lilly and Company
UCB
Article History
Received: 22 November 2023
Accepted: 30 March 2024
First Online: 8 May 2024
Declarations
:
: Human research ethics approval for storage of the central dataset and analyses of the pooled data, was obtained from the Monash University Human Research Ethics Committee (MUHREC Project ID 18778), and all research subjects signed the informed consent form prior to commencement of the study.
: Not applicable.
: Authors R.M., M.H., E.M., and M.N. have received grant support or consulting fees from pharmaceutical sponsors. Author C.K. is an employee of Janssen.